---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-032798"
form_type: "8-K"
ticker: "AMIX"
cik: "0001617867"
company_name: "Autonomix Medical, Inc."
filed_at: "2025-11-03T23:59:59+00:00"
generated_at: "2026-05-17T00:53:26.085935+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Autonomix Medical stockholders approve reverse split, expanded equity plan at annual meeting

## Summary
- All five director nominees elected; Forvis Mazars ratified as auditor for FY ending Mar 2026.
- Reverse stock split authorized at ratio of 1-for-2 to 1-for-25, board discretion for one year.
- Amended and restated 2023 Equity Incentive Plan approved, increasing authorized shares by 1.9M to ~2.27M.
- Issuance of >20% of outstanding common stock to Lincoln Park Capital Fund, LLC approved.
- Total shares voted 2,871,639 (48% of outstanding) constituting a quorum.

## SEC filing metadata
- accession: 0001437749-25-032798
- form_type: 8-K
- ticker: AMIX
- cik: 0001617867
- company_name: Autonomix Medical, Inc.
- filed_at: 2025-11-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1617867/000143774925032798/0001437749-25-032798-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1617867/000143774925032798/amix20251030_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-032798
- JSON: https://secwatch.observer/filing/0001437749-25-032798.json
- Plain text: https://secwatch.observer/filing/0001437749-25-032798.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.